Rani Therapeutics Holdings Cash Flow Statement (2020-2025) | RANI

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -2.71M-2.88M-5.76M-5.60M-5.49M-28.70M-13.30M-13.83M-15.97M-16.21M-17.37M-16.83M-18.66M-18.33M-14.05M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M-8.50M
Depreciation and Depletion (Quarter) 0.14M0.13M0.12M0.12M0.11M0.12M0.14M0.13M
Share-based Compensation (Quarter) 0.45M0.28M18.70M3.17M2.90M3.98M4.40M4.50M4.42M5.14M4.97M4.49M3.87M4.13M4.04M3.99M3.92M3.29M2.34M2.24M
Gains from Sales and Divestitures (Quarter) 0.02M0.02M0.02M0.03M0.27M0.27M0.03M0.02M0.39M0.16M0.22M0.27M0.00M
Gains from Investment Securities (Quarter) -0.67M0.72M0.22M2.29M0.09M3.69M0.06M0.11M0.13M-0.13M0.04M4.15M-4.73M0.02M4.15M1.63M
Non-cash Items (Quarter) 0.06M0.98M27.80M0.60M9.70M13.38M4.71M16.40M6.46M7.18M
Cash from Operations (Quarter) 0.67M-6.70M-4.05M-5.63M-11.12M-11.45M-9.36M-10.33M-12.20M-14.63M-12.15M-12.30M-14.30M-12.48M-9.40M-9.03M-8.41M-8.65M-8.15M-5.80M-5.06M0.31M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.16M-0.16M0.21M0.55M0.70M0.54M-0.46M0.26M0.34M0.29M0.31M0.31M0.15M0.81M0.47M-1.15M
Amortization of Deferred Charges (Quarter) 0.02M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.03M
Depreciation & Amortization (CF) (Quarter) 0.14M0.14M0.13M0.12M0.11M0.11M0.12M0.14M0.17M0.19M0.19M0.22M0.23M0.25M0.26M0.26M0.27M0.25M0.24M0.22M0.19M
Change in Working Capital
Change in Receivables (Quarter) -3.05M0.60M-1.03M2.47M
Change in Account Payables (Quarter) -3.26M-0.18M0.20M0.54M-0.06M-0.69M0.08M0.13M0.17M-0.21M0.08M-0.41M0.40M-0.66M0.16M-0.30M1.06M-0.21M0.16M0.28M0.67M-2.16M
Change in Accured Expenses (Quarter) 0.05M-0.38M0.82M0.73M0.79M-1.61M0.65M0.80M0.94M-1.78M0.32M1.38M-0.08M-2.17M0.88M-0.20M-0.63M0.29M0.17M0.39M-0.55M3.18M
Investing Activities
Capital Expenditures (Quarter) 0.22M0.80M0.10M-0.10M0.23M-0.09M0.25M0.09M0.01M0.00M0.09M-0.05M1.02M0.17M0.05M0.06M0.12M0.03M0.09M
Change in Acquisitions & Divestments (Quarter) 3.00M23.00M35.00M23.50M22.85M20.35M18.20M18.70M20.30M21.00M5.75M
Cash from Investing Activities (Quarter) -0.26M-0.10M-0.14M-0.27M-0.25M-0.38M-71.35M-0.46M4.12M0.79M11.67M13.27M10.29M6.53M0.47M2.52M18.23M5.71M-30.97M
Financing Activities
Other financing activities (Quarter) -0.30M2.19M-1.89M0.11M0.15M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 0.16M1.72M-1.72M1.72M14.67M14.90M
Long-Term Debt Repayments (Quarter) 1.25M3.75M3.75M3.75M3.75M9.47M
Change in Capital Stock
Shares Issued (Quarter) 0.01M-0.01M73.65M0.05M-0.15M0.13M-0.13M0.04M0.12M-0.09M8.88M-0.36M0.04M3.90M-3.53M
Preferred Shares Issued (Quarter) 68.49M6.32M
Misc.
Cash from Financing Activities (Quarter) 2.78M68.65M7.75M-1.58M71.55M-0.57M0.05M14.08M14.87M0.01M0.08M0.05M0.10M0.12M0.14M7.70M5.62M-3.73M0.19M-1.01M44.85M
Change in Cash (Quarter) 3.45M61.69M3.60M-7.35M60.43M-12.29M-9.61M-10.66M-69.46M-0.21M-8.02M-11.43M-2.58M0.89M1.01M-2.36M-0.24M-0.52M6.35M0.10M-6.07M14.17M
Free Cash Flow (Quarter) 0.45M-7.50M-4.15M-5.53M-11.36M-11.36M-9.61M-10.41M-12.21M-14.63M-12.24M-12.25M-15.33M-12.64M-9.45M-9.09M-8.54M-8.69M-8.15M-5.88M-5.06M0.31M
Net Cash Flow (Quarter) 3.45M61.69M3.60M-7.35M60.43M-12.29M-9.61M-10.66M-69.46M-0.21M-8.02M-11.43M-2.58M0.89M1.01M-2.36M-0.24M-0.52M6.35M0.10M-6.07M14.19M